First Time Loading...

Natco Pharma Ltd
NSE:NATCOPHARM

Watchlist Manager
Natco Pharma Ltd Logo
Natco Pharma Ltd
NSE:NATCOPHARM
Watchlist
Price: 1 027.9 INR 0.66% Market Closed
Updated: Apr 28, 2024

Wall Street
Price Targets

NATCOPHARM Price Targets Summary
Natco Pharma Ltd

Wall Street analysts forecast NATCOPHARM stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for NATCOPHARM is 880.1 INR with a low forecast of 626.2 INR and a high forecast of 1 181.25 INR.

Lowest
Price Target
626.2 INR
39% Downside
Average
Price Target
880.1 INR
14% Downside
Highest
Price Target
1 181.25 INR
15% Upside
Natco Pharma Ltd Competitors:
Price Targets
600200
JiangSu WuZhong Pharmaceutical Development Co Ltd
5% Downside
600329
Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd
31% Upside
603566
Pulike Biological Engineering Inc
53% Upside
APLLTD
Alembic Pharmaceuticals Ltd
12% Downside
ORCHPHARMA
Orchid Pharma Ltd
9% Upside

Revenue
Forecast

Revenue Estimate
Natco Pharma Ltd

For the last 8 years the compound annual growth rate for Natco Pharma Ltd's revenue is 16%. The projected CAGR for the next 3 years is 22%.

16%
Past Growth
22%
Estimated Growth
Estimates Accuracy
-4%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Natco Pharma Ltd

For the last 8 years the compound annual growth rate for Natco Pharma Ltd's operating income is 21%. The projected CAGR for the next 3 years is 33%.

21%
Past Growth
33%
Estimated Growth
Estimates Accuracy
-10%
Average Miss

Net Income
Forecast

Net Income Estimate
Natco Pharma Ltd

For the last 8 years the compound annual growth rate for Natco Pharma Ltd's net income is 23%. The projected CAGR for the next 3 years is 35%.

23%
Past Growth
35%
Estimated Growth
Estimates Accuracy
-1%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is NATCOPHARM's stock price target?
Price Target
880.1 INR

According to Wall Street analysts, the average 1-year price target for NATCOPHARM is 880.1 INR with a low forecast of 626.2 INR and a high forecast of 1 181.25 INR.

What is Natco Pharma Ltd's Revenue forecast?
Projected CAGR
22%

For the last 8 years the compound annual growth rate for Natco Pharma Ltd's revenue is 16%. The projected CAGR for the next 3 years is 22%.

What is Natco Pharma Ltd's Operating Income forecast?
Projected CAGR
33%

For the last 8 years the compound annual growth rate for Natco Pharma Ltd's operating income is 21%. The projected CAGR for the next 3 years is 33%.

What is Natco Pharma Ltd's Net Income forecast?
Projected CAGR
35%

For the last 8 years the compound annual growth rate for Natco Pharma Ltd's net income is 23%. The projected CAGR for the next 3 years is 35%.